Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4

• Main Authors: Nada M.K. Mabrouk (Author), Dalal M. Elkaffash (Author), Mona Abdel-Hadi (Author), Salah-ElDin Abdelmoneim (Author), Sameh Saad ElDeen (Author), Gihan Gewaifel (Author), Khaled A. Elella (Author), Maher Osman (Author), Nahed Baddour (Author)
• Format: Book
• Published: AboutScience Srl, 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Molecular targeted drugs are the first line of treatment of advanced hepatocellular carcinoma (HCC) due to its chemo- and radioresistant nature. HCC has several well-documented etiologic factors that drive hepatocarcinogenesis through different molecular pathways. Currently, hepatitis C...